RCEL · Nasdaq, OTC · CIK 0001762303

AVITA Medical, Inc.

AVITA Medical, Inc.’s most recent SEC filing in our snapshot is a Form S-8 filed on Aug 25, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of $71.6M and net income of -$48.6M, according to its XBRL data on EDGAR. Its EDGAR record lists 19 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2025
$71.6M
Net income, FY2025
-$48.6M
Form 4 filings on record, past 12 months
19

Company overview

Legal name (as filed)
AVITA Medical, Inc.
Tickers
RCEL, AVHHL
SEC Central Index Key (CIK)
0001762303
Business address
VALENCIA, CA
State or country of incorporation
DE
Fiscal year ends
December 31
SEC filer category
Non-accelerated filer<br>Smaller reporting company
Position in SEC ticker list
#2945 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from AVITA Medical, Inc.’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
$29.2MFY2021$34.4MFY2022$50.1MFY2023$64.3MFY2024$71.6MFY2025
Net income
-$26.6MFY2021-$26.7MFY2022-$35.4MFY2023-$61.8MFY2024-$48.6MFY2025
RCEL annual results
ItemFY2021
ended Jun 30, 2021		FY2022
ended Dec 31, 2022		FY2023
ended Dec 31, 2023		FY2024
ended Dec 31, 2024		FY2025
ended Dec 31, 2025
Revenue$29.2M$34.4M$50.1M$64.3M$71.6M
Net income-$26.6M-$26.7M-$35.4M-$61.8M-$48.6M
Diluted EPS$1.17$1.07-$1.40-$2.39-$1.74
Total assets$125.5M$98.3M$111.6M$79.7M$56.4M
Cash and equivalents$110.7M$18.2M$22.1M$14.1M$10.2M

XBRL tags used: revenue = Revenues; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

RCEL latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Feb 12, 202610-KAnnual report· period Dec 31, 2025Document · Index
Aug 6, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Aug 11, 20268-KMaterial agreement· period Aug 5, 2026Document · Index
Apr 22, 2026DEF 14ADefinitive proxy statement· period Apr 22, 2026Document · Index
Oct 31, 201920-FAnnual report of a foreign private issuer· period Jun 30, 2019Document · Index
Jun 22, 20206-KReport of a foreign private issuer· period Jun 22, 2020Document · Index

Recent SEC filings

The 40 newest documents filed by or about AVITA Medical, Inc., by form type:

4 ×198-K ×710-Q ×23 ×1S-8 ×14/A ×18-K/A ×1424B5 ×1DEF 14A ×1EFFECT ×1PRE 14A ×1CORRESP ×1UPLOAD ×1S-3 ×110-K ×1
RCEL recent filings
FiledFormWhat it isOriginal
Aug 25, 2026S-8Registration of employee benefit plan securitiesDocument · Index
Aug 24, 20264/AStatement of changes in beneficial ownership (insider trade)· period Jun 12, 2026Document · Index
Aug 11, 20268-KMaterial agreement· period Aug 5, 2026Document · Index
Aug 6, 20268-K/AShareholder vote results· period Jun 3, 2026Document · Index
Aug 6, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Aug 6, 20268-KResults of operations· period Aug 6, 2026Document · Index
Jun 12, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 12, 2026Document · Index
Jun 10, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 9, 2026Document · Index
Jun 9, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 9, 2026Document · Index
Jun 8, 20268-KMaterial agreement· period Jun 5, 2026Document · Index
Jun 8, 2026424B5424B5Document · Index
Jun 5, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 3, 2026Document · Index
Jun 4, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 3, 2026Document · Index
Jun 4, 20268-KDirector or officer change; Shareholder vote results· period Jun 3, 2026Document · Index
Jun 4, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 3, 2026Document · Index
Jun 4, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 3, 2026Document · Index
Jun 4, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 3, 2026Document · Index
Jun 4, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 3, 2026Document · Index
Jun 4, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 3, 2026Document · Index
Jun 3, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 1, 2026Document · Index
Jun 1, 20264Statement of changes in beneficial ownership (insider trade)· period May 29, 2026Document · Index
Jun 1, 20264Statement of changes in beneficial ownership (insider trade)· period May 29, 2026Document · Index
May 20, 20264Statement of changes in beneficial ownership (insider trade)· period May 20, 2026Document · Index
May 19, 20264Statement of changes in beneficial ownership (insider trade)· period May 19, 2026Document · Index
May 14, 202610-QQuarterly report· period Mar 31, 2026Document · Index
May 14, 20268-KResults of operations· period May 14, 2026Document · Index
May 1, 20268-KDirector or officer change; Regulation FD disclosure· period Apr 30, 2026Document · Index
Apr 22, 2026DEF 14ADefinitive proxy statement· period Apr 22, 2026Document · Index
Apr 9, 2026EFFECTEFFECTDocument · Index
Apr 8, 2026PRE 14APRE 14A· period Apr 8, 2026Document · Index
Apr 7, 2026CORRESPCORRESPDocument · Index
Apr 6, 2026UPLOADUPLOADDocument · Index
Mar 31, 2026S-3Simplified registration statementDocument · Index
Mar 11, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 11, 2026Document · Index
Mar 6, 20263Initial statement of beneficial ownership· period Jan 1, 2026Document · Index
Feb 23, 20264Statement of changes in beneficial ownership (insider trade)· period Feb 19, 2026Document · Index
Feb 19, 20264Statement of changes in beneficial ownership (insider trade)· period Feb 18, 2026Document · Index
Feb 19, 20264Statement of changes in beneficial ownership (insider trade)· period Feb 18, 2026Document · Index
Feb 12, 202610-KAnnual report· period Dec 31, 2025Document · Index
Feb 12, 20268-KResults of operations· period Feb 12, 2026Document · Index

Insider filing activity

19 Form 4 filings appear in AVITA Medical, Inc.’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Surgical & Medical Instruments & Apparatus

All 51 companies in Surgical & Medical Instruments & Apparatus· Companies headquartered in California

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Electronics Plaud Note Pro AI Voice Recorder An AI voice recorder that turns earnings calls and meetings into notes. View on Amazon → Electronics Amazon Kindle Paperwhite Signature Edition 32GB Read investing classics and long reports without eye strain. View on Amazon → Electronics Apple 2026 MacBook Air 13-inch Laptop A lightweight laptop for spreadsheets and filing research. View on Amazon →

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001762303 and XBRL company facts. AVITA Medical, Inc. on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.